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detection limit is about 0.2 mol/L. The within-run precision
(CV) is about 10%, both at high and low concentrations of bile acids in serum. Correlation is good (r = 0.996) between results by this method and an enzymatic method based on spectrophotometry. However, the latter method is considerably less sensitive, and it is less precise at low concentrations of bile acids.
AddItIonal Keyphrases: liver disease enzymic methods kinetic methods cholate
Increased concentrationsof bile acids in serum, the result of shunting of systemic portal blood or a decreased hepatic uptake, are an early and sensitive sign of liver disease (1, 2) .
In spite of the documented diagnostic sensitivity and specificity, determination of bile acids has not yet been included in the battery of tests in general use for diagnosis of liver diseases (1), in part because the commonly used methods for bile acids in serum are fairly complicated. Gasliquid chromatography is highly specific and can be used to determine individual bile acids (3, 4) , but is rather insensitive and very time-consuming. Radioimmunoassay (1, 5 ) is relatively specific and sensitive, but is expensive and laborious. At present, only the enzymatic methods involving the NAD-consuming 3a-hydroxysteroid dehydrogenase (3a- (10, 11) or enzyme recycling (12). Such modifications increase the sensitivity but often decrease the practicability.
We report here our efforts to develop a sensitive but simple and practical assay for bile acids in serum by use of the 3a-hydroxysteroid dehydrogenase reaction,coupled to a bacterial bioluminescence system. The potential for high sensitivity in the latter step is well established
(13).
Assay of NADH by bacterial bioluminescence involves two enzymes: NADH:FMN-oxidoreductase (OR) reduces flavim mononucleotide (FMN) to FMNH2, which is oxidized in the light-producing reaction catalyzed by bacterial luciferase (BL). In the second reaction, oxygen and an aliphatic straight-chain aldehyde with eight to 14 carbon atoms are required as illustrated in the reaction schemes:
Bacterial bioluminescence has been used to analyze numerous substrates and dehydrogenase activities involved in NADH-producing reactions, e.g., malate (14, 15) , malate dehydrogenase (14, 16), lactate dehydrogenase (16), alcohol dehydrogenase (13, 16, 17) , ethanol (13, 16, 18) and oxaloacetate (14) . Steroids have been assayed by use of dehydrogenases, BL, and OR co-immobilized on Sepharose 4B (19) .
In most of the above studies, the composition of the reagents has not been defined in terms of activities of BL and OR,andthedetailed kinetic properties of the preparations have not been known.
If a purified reagent with a low OR activity and a high BL activity is used, the light emission stays almost constant for several minutes in response to 10#{176} to 10-6 mol of NADH per liter, because the low OR content results in negligible consumption of NADH during the reaction. Substrates and enzymes in NADH-producing reactions can thus be kinetically determined by continuously monitoring the changes in light intensity (13).
In the present work we have used 3a-HSD and a commercially available purified BL/OR reagent that seems to fulfill the above requirements for assay of bile acids in serum. 
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1124 CLINICAL CHEMISTRY, Vol. 29, No. 6, 1983 Results by this assay are compared with those by a routine method based on the 3a-HSD reaction and spectrophotometry (20). BSA (essentially fatty-acid free, cat. no. A 6003; Sigma Chemical Co.), 13 g/L, dissolved in potassium phosphate buffer (0.2 molIL, pH 7.9) was added to the working reagent for the bioluminescent assay, because albumin reportedly narrows the difference between the reaction rates for the various bile acids (20) . Serum samples and bile acid standards were diluted in a 50 g/L solution of BSA in water.
Materials and Methods

Reagents
Working reagent for the bioluminescent assay was prepared by mixing 2.5 mL of BL/OR reagent with 6.9 mL of BSA, 13 g/L, and 375 L of Decanal, 6.64 mmolIL (for 25 assays). The final pH of the working reagent was 7.9 ± 0.05. 
Bile Acids
Other chemicals.
FMN, cholic acid, sodium cholate, deoxycholicacid, and chenodeoxycholic acid were all from Sigma Chemical Co. Other chemicals were of analytical grade.
De-ionized water purified by reversed osmosis was used throughout this study.
Solutions of all reagents were freshly prepared each day. All reagents, including the working reagent, are stable for at least 3 h at 25 #{176}C.
Procedures
Spectrophotometric assay of bile acids. We determined bile acids spectrophotometrically at 37 #{176}C, using the reagent "Sterognost-3aRRA" (Nyegaard & Co A/S) according to the method described by Steensland (20) and the recommendations of the manufacturer. The assays were performed in a Reaction Rate Analyzer 2086 equipped with a Flat Bed Potentiometer Recorder (both from LKB Sverige AB, S-161 26 Bromma, Sweden) and a separate Hewlett-Packard 9815 Calculator, programmed for analysis of bile acids. The measuring interval was set at 5 mm. The actual concentration of the bile acids was calculated by comparison with a standard curve. Measure the increase in light emission during the initial 20 s, which is directly proportional to the concentration of bile acids in the sample. Calculate the actual concentrations of the bile acids by comparison with a standard curve.
Results
After mixing a sample containing bile acids with TCA, working reagent, and NAD and initiating the reaction by adding 3a-HSD, we noted a gradually increasing light intensity.
The initial increase in light per unit time, measured during about 20 s, was used to calculate the concentration of bile acids. Figure 1 
The optimum pH for the bioluminescent assay of bile acids depends on the pH optima of the three reactions involved. The pH optimum of the 3a-HSD reaction is 9.5 in pyrophosphate buffer (22) . Assay of OR by spectrophotometry gives increasing values from pH 6.5 to pH 8.5 (21). The optimum pH of the BL reaction is about 7.0 (data not shown). In the coupled reaction involving all three enzymes, the pH optimum was found to be 7.3. The value for the reagent blank in the assay of bile acids was also maximum at pH 7.3 (results not shown). Figure 2 shows the results from an experiment in which dehydrogenases present in the reference serum (Seronorm Lipid) were inactivated with TCA. Seronorm Lipid, 10 L, was mixed with various concentrations of TCA and analyzed with and without 3a-HSD. When we used 10 L of 75 g/L TCA, the endogenous dehydrogenase activity observed in the absence of added 3a-HSD was inhibited by 95% and the 3a-HSD-dependent signal from the assay of bile acids was reduced by 20%. Essentially identical results were obtained with serum samples. To increase the precision, we used 20 L each of sample and TCA in the finally adopted procedure. The TCA-dependent inhibition of the reaction rate in this experiment was in part due to the pH change, because To get a final pH of 7.3 in the reaction mixture under the standard conditions, the initial pH of the buffer must be 7.9, the pH used in the finallyadopted procedure.
The rate of light emission increased linearly with increasing amounts of 3a-HSD in the interval examined ( Figure  3a) . The optimum concentration of Decanal was 0.2 mmol/L (Figure 3b) . The apparent Km for NAD in the bioluminescent assay of cholate is 0.14 mmollL. The NAD concentration used in the finally adopted procedure, 0.8 mmollL, is well above this (Figure 3c) .
Results by the bioluminescent assay were linearly related to the concentration of cholate up to at least 300 .tmo1JL ( Figure   4 ). The standard curve obtained with Bile Acid Standards RRA was almost identical with that obtained with cholate alone. A standard curve obtained with chenodeoxycholate gave about 20% lower values and the corresponding curve obtained with deoxycholate gave about 40% higher values than that obtained with cholate.
The reagent blank in the assay of cholate corresponded to a sample containing approximately 1 (SD 0.1) prnol of cholate per liter (Figure 4) . Thus the lowest detectable concentration of cholate by the present method is 0.2 prnoll L, corresponding to the average reagent blank + 2 S.D., i.e., outside the upper limit of the 95% confidence interval for the reagent-blank value.
Appliedto serum specimens, the present method correlated well (r 0.996) with the spectrophotometric method ( Figure 5) . The linear regression equation was y = 1.13x -0.46. The slope was significantly (p < .005) different from 1.0, whereas the intercept was not significantly different from 0 (p> .05). Table 1 gives the within-run and between-run precision obtained for the bioluminescent and the spectrophotometric methods. The within-run precision for the spectrophotomet.. nc method was poor for low concentrations of bile acids: CV = 32% at 2.6 zmol!L. For values near the upper limit of the normal range (7 p.moL'L), the two methods had about the 
Discussion
Owing to the recent availability of standardized reagents, there is a growing interest in the possible application of bioluminescence to routine clinical analysis (23, 24) . Its simplicity and sensitivity are the most attractive features of this technique. In enzymatic determination of serum bile acids, the lack of sensitivity of spectrophotometric procedures has been a problem. According to the manufacturer of the enzymatic kit used here for assay of serum bile acids by spectrophotometry, the detection limit should be about 1 mol/L, but in our hands it was considerably higher. In contrast, the detection limit for the bioluminescent assay is about 0.2 tmo1IL for a sample volume only one-tenth that used in the spectrophotometric assay.
In the spectrophotometric as well as in the bioluminescent method for assay of bile acids in serum, a major problem is the need to inactivate the nonspecific dehydnogenase activities in the sample. In the spectrophotometric method (20) the sample must be incubated with buffer at 65 #{176}C for 35 mm before the assay. Because the method is relatively insensitive, large (200 L) samples must be inactivated and analyzed. In the bioluminescent method the sample required is much less and the dehydrogenases are inactivated with a fast and simple one-step procedure. The entire assay, including treatment with TCA, can be done directly in the test tube, without sub-sampling. The high sensitivity also makes it possible to increase the linear range of the assay. Under the present conditions, the bioluminescent assay of bile acids was linear up to at least 300 molJL whereas the spectrophotometric method was linear to only 30 mo1/L
(20).
The enzyme 3a-HSD is highly specific for 3cr-OH steroids (25) .
In addition to bile acids this enzyme can also use some steroids in the C19 and C21 series as substrates. Of these, only some pregnan metabolites may occur in serum in concentrations high enough to influence the assay of bile acids. However, in practice, these metabolites should not cause any problems.
Reportedly, some preparations of 3a-HSD may contain small amounts of malate dehydrogenase (26) . Any malate in serum samples could thus give falsely high concentrations of bile acids when assayed with an enzymatic method. In the present bioluminescent method, however, no interference by malate dehydrogenase could be detected with as much as 10 mol of malate per liter of sample.
1126 CLINICAL CHEMISTRY, Vol. 29, No. 6, 1983 To summarize, the present bioluminescent method for assay of bile acids in serum is not more complicated than the corresponding spectrophotometnic method. It is considerably more sensitive and has a broader linear range and a higher within-run precision at low concentrations of bile acids. In addition, it is rapid and well suited for automation and use in clinical routine.
Note added in pf
After this paper was accepted, Roda et al. (27) described a bioluminescent method for bile acids in which immobilized 7a-hydroxysteroid dehydrogenase was used.
